| Document |
Document Title |
|
WO/2002/088155A1 |
The present invention relates to the production of xylitol. In particular, processes utilising L-xylose as an intermediate for xylitol production are described. The present invention also relates to process for the preparation or L-xylos...
|
|
WO/2002/088154A1 |
The present invention relates to process for the preparation or L-xylose, as an intermediate, by-product or end-product to be used per se. Further processes utilising L-xylose as an intermediate for xylitol production are described.
|
|
WO/2002/083701A1 |
A means for inhibiting decomposition products, isomerization products, colored substances, etc. from generating in the desalting of a sugar solution and for thereby inhibiting the generation of impurities and preventing an ion-exchange r...
|
|
WO/2002/076195A1 |
The subject invention pertains to a transgenic animal model for tumorigenesis having a genome comprising a ras transgene and which is heterozygous or homozygous for a null p27 gene, and methods of using such animal to screen compounds or...
|
|
WO/2002/072594A1 |
A novel glycosyl derivative which is a cyclic tetrassacharide represented by cyclo{$m(7)6)-$g(a)-D-glucopyranosyl-(1$m(7)3)-$g(a)-D-gluco
pyranosyl-(1$m(7)6)-$g(a)-D-glucopyranosyl-(1$m(7)3)-$g(a)-D
-glucopyranosyl-(1$m(7)}. It is a bran...
|
|
WO/2002/066496A1 |
A modifier characterized by containing as the active ingredient a compound represented by the formula (I) (wherein X is OH, OSO¿3?H, or OCH¿3? and R is a substituent excluding OH). The modifier is applied to a substance having reactivi...
|
|
WO/2002/058633A2 |
Described is a modular, general synthetic strategy for the preparation in solution and on a solid support of heparin, heparin-like glycosaminoglycans, glycosaminoglycans and non-natural analogs of each of them. Additionally, the modular ...
|
|
WO/2002/059300A2 |
The present invention relates to methods for modifying gene expression and in particular to methods for controlling gene expression in eukaryotic cells using double-stranded RNA (dsRNA), and to eukaryotic cell lines in which gene express...
|
|
WO/2002/056893A1 |
The present invention describes a substance or a receptor comprising $i(Helicobacter pylori) binding oligosaccharide sequence [Gal(A)¿q?(NAc)¿r?/Glc(A)¿q?(NAc)¿r?$g(a)3/$g(b)3]¿s?[G
al$g(b)4GlcNAc$g(b)3]¿t?Gal$g(b)4Glc(NAc)¿u? whe...
|
|
WO/2002/057011A1 |
A dehydrating agent comprising a cyclic tetra-saccharide, which is defined in the specification, as an effective component; a method for dehydrating a moist article, characterized in that the moist article is incorporated into, is contac...
|
|
WO/2002/053783A1 |
The invention relates to a process of producing a xylose solution from a biomass hydrolysate by subjecting the biomass hydrolysate to nanofiltration and recovering as the nanofiltration permeate a solution enriched in xylose. The biomass...
|
|
WO/2002/051264A2 |
A nutritional composition having beneficial effect in the gastrointestinal tract, especially an anti-adhesion effect on pathogenic micro-organisms and a bifidogenic effect, contains non-digestible oligosaccharides, said oligosaccharides ...
|
|
WO/2002/050089A1 |
The present invention relates to improved methods of purification of sugars and in particular to a method of preparing lactose. A low purity lactose source such as whey is subjected to a first demineralisation step involving either ion-e...
|
|
WO2000052018A9 |
In certain embodiments, the present invention relates to versatile linkers for tethering a molecule to a solid support, e.g. for tethering a monomer, oligomer or polymer to a solid support, which are stable to a wide range of reaction co...
|
|
WO/2002/050257A2 |
The invention relates to nucleic acids coding for modified polypeptides with fructosyltransferase activity, the vectors containing said nucleic acids for the expression of the modified fructosyltransferase in prokaryotic or eukaryotic ce...
|
|
WO/2002/048163A2 |
Disclosed are novel synthetic processes for the preparation of $g(a)Gal(1$m(7)4) $g(b)Gal(1$m(7)4)Glc-OR trisaccharides.
|
|
WO/2002/044194A1 |
A novel process for preparing 2,2'-anhydro-1-(ß-L- arabinofuranosyl)thymine which is novel and a useful intermediate; a novel process for preparing L-thymidine from 2,2'-anhydro-1-(ß-L-arabinofuranosyl)thymine; and a novel process for ...
|
|
WO/2002/044190A2 |
Disclosed are novel synthetic processes for preparation of the trisaccharide $g(a)Gal(1$m(7)3)$g(b)Gal(1$m(7)4)Glc-OR compounds.
|
|
WO/2002/036600A2 |
In a composition comprising a therapeutic agent and a compound which is a trisaccharide or higher polysaccharide, that compound has the formula X[-Y-Z]¿n? wherein X and Z are each saccharide molecules in which none, some or all OH group...
|
|
WO/2002/032914A2 |
Acylated cellobiose compounds (CHME) which satisfy the formula:- wherein X represents an acyl group (R-CO-) or H, Z represents an acyl group (R'-CO-) or H and not more than a minority of X + Z residues represent H, R represents a saturat...
|
|
WO/2002/027039A1 |
The present invention relates to a method for recovering a monosaccharide selected from the group consisting of rhamnose, arabinose, xylose and mixtures thereof from a solution containing the same by a multistep process using chromatogra...
|
|
WO/2002/027037A1 |
The invention relates to a method comprising a multistep process for recovering betaine, erythritol, inositol, sucrose, mannitol, glycerol and amino acids from corresponding starting materials. The invention comprises the use of a weakly...
|
|
WO/2002/026701A2 |
Ionic compounds with a freezing point of up to 100 °C are formed by the reaction of an one amine salt of formula (I) R?1¿ R?2¿ R?3¿ R?4¿ N?+¿ X?-¿, such as choline chloride with an organic compound (II) capable of forming a hydrog...
|
|
WO/2002/024832A1 |
The invention aims at providing a method for protecting unsaturated compounds from chemical changes due to radical reactions by inhibiting the conversion of unsaturated compounds into radicals. This aim is attained by an aggregate-formin...
|
|
WO/2002/020712A1 |
The invention is directed to a brewing process for making a fermented product having an increased dietary fibre content and to a fermented product having an increased content of soluble dietary fibre.
|
|
WO/2002/018449A1 |
The present invention provides a new class of compounds presenting a high compatibility with tissues and organic fluids. Such new compounds are polysaccharides essentially formed of units of uronic acid and/or hexosamine, containing nitr...
|
|
WO/2002/018603A1 |
Isomaltulose synthase (sucrose, EC 5.4.99.11) converts surcrose to isomaltulose (6-O-$g(a)-D-glucopyranosyl-D-fructofuranose). The enzyme has been isolated from Erwinia rhapontici and an additional bacterial isolate 68J. Also disclosed a...
|
|
WO/2002/016384A2 |
One aspect of the present invention relates to an apparatus for the efficient synthesis of oligosaccharides on a solid support, e.g., formed by subunit addition to terminal subunits immobilized on solid-phase particles. In certain embodi...
|
|
WO/2002/016438A2 |
A tailor-assembly approach is employed for synthesis of complex carbohydrates wherein a polysaccharide is degraded and the shorter product obtained from the degradation is subjected to enzymatic modification to add a sugar moiety. The pr...
|
|
WO/2002/012257A1 |
A process for producing crystalline tagatose from an aqueous system containing no organic solvents. The process comprises adding seed tagatose crystals to a tagatose solution which has a solid concentration of 60 to 98 wt.% and in which ...
|
|
WO/2002/010361A1 |
$g(a)-Isomaltosylglucosaccharide synthase capable of transferring a-glucosyl from a saccharide, which carries an $g(a)-glucosyl bond as the binding manner at the nonreducing end and has a degree of glucose polymerization of at least 2, w...
|
|
WO/2002/007778A1 |
The present invention relates to a composition for determining the lactase activity in a mammal. By means of the composition the lactase activity of a mammal, in particular a human being, can be determined in a manner that causes little ...
|
|
WO/2002/008239A1 |
The invention relates to novel disaccharides of formula (I), wherein R?1¿ is selected from the group consisting of hydrogen, linear or branched (C¿1?-C¿4?) alkyl, phenylalkyl with less than ten carbon atoms and -COCH¿3?; R?2¿ is sel...
|
|
WO/2002/008238A1 |
A crystalline mannose which contains substantially no organic solvent, has a melting point of 133 to 135 ° as measured by the DSC measurement and has a purity of 96 % or more. The crystalline mannose can be produced by a method which co...
|
|
WO/2002/002150A2 |
Methods are described for conjugating radioiodinated peptides to non-metabolizable carbohydrates with improved yields and qualities of conjugates. Radioiodinated residualizing antibody conjugates comprising a carbohydrate-appended peptid...
|
|
WO/2002/002581A1 |
Molasses-containing maltitol crystals which, when pulverized and classified so as to give a powder at least 70 wt.% of which is accounted for by 16- to 50-mesh particles, has an oil absorption of 0.1 to 6.9 wt.% and a bulk density of 0.6...
|
|
WO/2001/097819A1 |
The present invention is directed to human influenza virus binding substance containing at least one oligosaccharide chain, which comprises a terminal NeuNAc$g(a)6 linked to: (a) a linear or branched polylactosamine type structure consis...
|
|
WO/2001/096281A1 |
Double fumarates of L-carnitine or isovaleryl L-carnitine and an amino acid are disclosed which are useful as active ingredients of food supplements, dietary supplements or drugs.
|
|
WO/2001/095915A1 |
A health food/dietary supplement is disclosed suitable for enhancing muscular energy metabolism, comprising as its characterising active ingredients an alkanoyl L-carnitine and ribose.
|
|
WO/2001/094367A1 |
Substances which hinder human $g(a)-amylase potently and are effective in the prevention and treatment of hyperglycemia such as diabetes and diseases due thereto; and $g(a)-amylase inhibitors and preventive or therapeutic drugs for hyper...
|
|
WO/2001/094356A1 |
An aqueous solution containing an alkali metal salt of a partial alkyl ester of phosphoric acid wherein the alkyl groups may be each linear or branched and have 16 to 22 carbon atoms on the average, the degree of phosphorylation is 0.6 t...
|
|
WO/2001/090299A2 |
A novel saccharide which is free from carbon-carbon double bond and carbonyl, is represented by the molecular formula: C6H10O5, and exhibits in high-performance liquid chromatography a retention time of 11.0 ± 0.2 min as determined by u...
|
|
WO/2001/090338A1 |
$g(a)-Isomaltosyltransferase capable of forming a cyclic tetrasaccharide having a cyclo { - 6} -$g(a)-D-glucopyranosyl- (1 - 3) -$g(a)-D-glucopyranosyl- (1 - 6) -$g(a)-D-glucopyranosyl- ( 1 - 3) -a-D-glucopyranosyl- ( 1 - ) structure via...
|
|
WO/2001/085745A1 |
Compounds having a mimetic or antagonistic property of an inositol phosphoglycan, and the uses of these compounds are disclosed, together with the use, e.g. to treat a condition ameliorated by administration of an IPG second messenger or...
|
|
WO/2001/083564A1 |
Soluble amphiphilic macrocycle analogues having lipophilic groups attached to one side of the units making up the macrocycle and hydrophilic groups attached to the other side. These amphiphilic macrocyclic derivatives have the ability to...
|
|
WO/2001/072698A1 |
The present invention relates to an optically active (2S,3R)-4-cyanobutan-1,2,3-triol derivative, a process for preparing same, and a process for preparing 2-deoxy-L-ribose from same.
|
|
WO/2001/061353A1 |
An array having a target substance immobilized at 2 or more points in a pre-determined region on a solid phase per cm?2¿ of a solid phase base, wherein the target substance is immobilized at 2 or more points at different concentrations ...
|
|
WO/2001/053306A2 |
The invention relates to the methods of manufacturing five-carbon sugars and sugar alcohols as well as other compounds derived from pentose-phosphate pathway from readily available substrates such a hexoses using metabolically engineered...
|
|
WO/2001/044450A1 |
The present invention provides a vector encoding trehalose-6-phosphate synthase (otsA)/trehalose-6-phosphate phosphatase (otsB) fusion protein and methods by which the fusion protein may be expressed in mammalian cells to provide enhance...
|
|
WO/2001/044489A2 |
The invention relates to methods for the hydrolysis of galactomannan compounds and various uses of the hydrolysate.
|
